Skip to main content

This job has expired

You will need to login before you can apply for a job.

Communications, Investment/PR Representative

Employer
Molecular Templates, Inc.
Location
New York, NY, USA
Start date
Jun 29, 2021

View more

Job Details

Company Description:

Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics. Our proprietary biologic drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases. MTEM currently has multiple clinical-stage ETB candidates in development including MT-5111, TAK-169, and MT-6402. Additional preclinical compounds derived from our ETB platform technology are being advanced toward clinical development. Additional information about Molecular Templates can be obtained at www.mtem.com.

Position Overview:

Molecular Templates is seeking a highly motivated and skilled IR/PR Representative to assist with public and investor communications in a manner that enhances the MTEM brand and supports our mission with advisors, shareholders, industry experts and employees. The role will also coordinate internal corporate communications and contribute content to various internal and external media sources.

Job Responsibilities:
  • Maintain positive relationships with shareholders by effectively managing influx of daily incoming and outgoing calls to shareholders and their representatives (includes securing adequate backup as needed)
  • Facilitate a comprehensive shareholder communications program with a focus on obtaining a 60% eDelivery rate to include the following touchpoints:
    • Welcome kits for investments
    • Quarterly newsletters for open and closed programs
  • Assist with and recommend communications to support transactions or unforeseen events
  • Facilitate announcement process and subsequent shareholder communications
  • Facilitate communication materials reviews coordinate legal and compliance review of materials: ensure approval is completed; include all appropriate backup; make required edits (diligently check changes); and effectively follow-through on obtaining required approvals from legal department, third-party managing broker dealer and obtaining FINRA letter(s)
  • Conference planning and execution
  • Coordinate the internal corporate communications program and assure consistency in message, style and content
  • Execute communications tactics execute a variety of campaigns and communications
  • Work under minimal supervision with good judgment
  • Ability to work in a fast-paced, high-growth environment

Qualifications:
  • 2+ years of experience in IR/PR whether corporate or agency based
  • S. diploma required (degree highly preferred);
  • Must have strong critical thinking skills, interpersonal communication skills, conflict resolution skills, be highly proactive and possess exceptional attention to detail
  • Microsoft Office; and proficiency with other office technology and software. Must have the ability and desire to learn other software as needed
  • Intermediate composition skills; ability and desire to learn and apply AP Style guidelines; strong grammar skills and ability to develop and edit a variety of content


Reporting Structure:

This position has no supervisory responsibilities. This position will report to the Chief Finance Officer.

Molecular Templates celebrates and supports our differences and is proud to be an Equal Employment Opportunity employer. We do not discriminate based upon race, religion, color, national origin, sex (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, veteran status, disability, or any other legally protected characteristic.

MTEM is committed to providing reasonable accommodations for qualified individuals. If you need assistance with your application due to a disability, you may contact us at: careers@mtem.com.

By submitting a resume for consideration, applicants verify that they have read MTEM's Applicant Privacy notice. https://www.mtem.com/privacy-policy

Molecular Templates Inc https://mtem.isolvedhire.com

Company

Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. Additional preclinical compounds derived from our ETB platform technology are being advanced toward clinical development.  Additional information about MTEM can be obtained at www.mtem.com.  

OWNERSHIP: Public

STOCK SYMBOL: MTEM

STOCK EXCHANGE: NASDAQ

Company info
Website
Phone
512-869-1555
Location
9301 Amberglen Blvd, Ste 100
Austin
TX
78729
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert